Nikolay T.
- Country
- Bulgaria
- Department
- Department of Gastroenterology
Research Overview
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- Efficacy and Safety of Risankizumab in Maintenance and Long-term Extension for Moderately to Severely Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Lutikizumab Versus Adalimumab for Safety and Efficacy in Adults with Moderately to Severely Active Ulcerative Colitis
Data & Insights
Has run more than one trial at 185 of 489 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating complex gastrointestinal conditions, with particular focus on moderately to severely active ulcerative colitis and Crohn's disease. Their research encompasses both traditional and innovative therapeutic approaches.
- Ulcerative Colitis Treatment Modalities
- Crohn's Disease Management
- Novel Therapeutic Solutions
Advanced Therapeutic Applications
The investigator works with targeted therapies and biologic treatments for inflammatory bowel conditions. Their expertise includes evaluating novel therapeutic compounds and alternative delivery methods for gastrointestinal medications.
- Biological Treatment Assessment
- Innovative Drug Delivery Systems
- Therapeutic Response Evaluation
Clinical Outcomes Research
Their work focuses on assessing clinical remission and disease activity changes in gastrointestinal conditions. The investigator evaluates both immediate therapeutic responses and long-term treatment outcomes.
- Treatment Efficacy Assessment
- Disease Activity Monitoring
- Long-term Patient Outcomes
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.